STD Self-testing Market Size & Share 2025 - 2034

STD Self-testing Market Size

The global STD self-testing market was estimated at USD 1.4 billion in 2024. The market is expected to grow to 2.4 billion in 2034, at a CAGR of 6% during the forecast period. STD self-testing refers to an individual's undertaking their own sample collection, which may include blood, saliva, or urine, and analysis using a home testing kit for sexually transmitted infection diagnosis.

The increasing prevalence of STDs across the globe is driving the advancements in the STD self-testing market. With conditions such as chlamydia, gonorrhea, syphilis, and HIV on the rise, there is a requirement for testing solutions that are easily accessible and safe to use. This highlights the importance of providing people with private and convenient ways to monitor their sexual health, overcoming the barriers associated with traditional visits across healthcare settings.
 

For instance, according to a report in 2024, chlamydia cases have expanded by 26% and gonorrhea cases by 157% in Australia over the past decade. The rising predominance of STDs highlights the requirement for private, trustable and at home testing packs that can help the individuals to screen their sexual wellbeing.
 

The importance of sexual health and the rates of STDs are continuously rising, driving the demand for STD diagnostic self-testing kits. Additionally, Increasing number of people are understanding the importance to recognize and treat STDs in a timely manner, which is stimulating the requirement for easy-to-use and trusted testing options that can provide quick and correct results. Further, constant innovations in self-testing kits, have made them accurate and user-friendly, owing to which these tests have become a suitable alternative among individuals looking for options to oversee their sexual wellbeing without compromising their privacy.
 

STD Self-testing Market Trends

• Recent developments in the STD self-testing technologies have improved the accuracy and reliability of these test kits. Many advanced STD self-testing kits are  leveraging immunoassay technology, lateral flow assay, and nucleic acid amplification, which is improving test accuracy, making test less invasive, and offering quicker test result. For example, few at home test kits such as bioLytical INSTI HIV Self-Test use a simple fingerstick method and give results in 1 minutes, making it more accessible and less invasive for users.
   
• The awareness about sexual health is increasing so does the demand for self-testing kits. Many public organizations are regularly promoting the tests especially in regions that have high STD rates, such as the Centers for Disease Control and Prevention (CDC) “TakeMeHome” program, started in March 2020, has now expanded its access to HIV self-testing across the U.S. The program distributed 5,323 HIV self-tests to 4,859 people in twelve-month duration, which helped them diagnose 18 new HIV patients, yielding a positive rate of 0.6%.
   
• Furthermore, vendors are providing mobile apps that assist users in performing assessments and interpreting the outcomes using smartphone cameras or AI. This addresses the challenge associated with accessibility for users with limited health literacy, while making the reading of results less error-prone. For example, EverlyWell enables consumers to order laboratory tests, provide samples, and receive results through a user-friendly online report, which simplifies interpretation.
   

Trump Administration Tariffs

• Tariffs on imports such as microelectronics, medical plastics, and diagnostic reagents from various countries such as China are likely to increase the cost of raw materials used in STD self-testing kits.
• Manufacturers mostly rely on cost-effective components such as lateral flow assay strips, microfluidic chips, and packaging materials sourced from Asia.
   
• These trade barriers make it difficult to maintain a steady supply of important parts. Delay in regulatory clearances, vendor shifts, and manufacturing adjustments could also lead to delays in launching or restocking self-testing kits, especially for high-demand STDs such as HIV, syphilis, and chlamydia.
   
• To stay competitive and ensure uninterrupted supply, many companies are now actively looking for new sourcing options in countries such as India, Vietnam, South Korea, and regions across Eastern Europe.
   

STD Self-testing Market Analysis 

Based on the application, the market is segmented into chlamydia/Gonorrhea (CT/NG) testing, syphilis testing, HIV testing, and other applications. The chlamydia/Gonorrhea (CT/NG) testing segment held revenue of USD 576.3 million in 2024, and the segment is poised for significant growth at a CAGR of 6.1% during the forecast period.
 

• The growth of this segment is highly accelerated due to the rise in cases of chlamydia and gonorrhoea globally, which significantly contribute to the demand for self-testing solutions. For instance, as per WHO 2024 statistics, about 1 million curable sexually transmitted infections (STIs) are acquired daily by individuals aged 15–49 years. Moreover, across the world, in 2020, approximately 128.5 million new cases of chlamydia infection were reported in individuals aged 15 to 49. This burden of disease shows the critical need for more effective and accessible chlamydia infection diagnostic tools, such as self-testing kits, which allows the individuals to test rapidly and conveniently.
   
• Further, growing awareness and education regarding the importance of early detection and treatment for chlamydia and gonorrhoea, combined with the affordability and ease of use of at-home testing kits are expected to further stimulate the market growth.
   
• Therefore, as the demand for more advanced and effective diagnostic tools continues to rise, the chlamydia/Gonorrhea (CT/NG) testing segment is anticipated to remain a critical part, contributing to the market growth.

Learn more about the key segments shaping this market

Download Free PDF

Based on the sample type, the STD self-testing market is segmented into blood-based test, urine-based test, oral based test. The blood-based test segment dominated the market with a market share of 57.2% in 2024.
 

• Blood based test kits are highly sensitive and can differentiate between various types of STDs with less false negatives compared to urine or oral samples. Due to their high sensitivity, the blood-based test is important for early discovery and convenient treatment, expanding their demand within the self-testing market.
   
• Blood-based tests are expected to continue to dominate the market due to their broad acceptance in both clinical and at-home testing situations. The precision and reliability of these tests drive their development, particularly in developed markets where buyers value high-quality diagnostic devices.
   
• Additionally, blood-based testing kits for STDs usually go through a strict regulatory examination, ensuring that they comply and meet all the measures for accuracy and safety. As a result, these tests are widely approved by health specialists, expanding their trust among end users.
   

Based on the distribution channel, the STD self-testing market is segmented into hospital pharmacy, retail pharmacy and online pharmacy. The online pharmacy segment is experiencing the fastest growth in the market with a market share of 33.3% in 2024.
 

• The growing preference for convenience and privacy has significantly driven the demand for STD self-testing kits through online pharmacies. As individuals increasingly seek hassle-free testing alternatives, online platforms enable them to access testing solutions directly from their homes without the need for clinical visits.
   
• Online pharmacies provide a wide range of self-testing kits, facilitating access to testing solutions for chlamydia, gonorrhea, HIV, and other STDs in both urban and rural areas. This accessibility has boosted the adoption of self-testing kits, as individuals prefer ordering tests from the comfort of their homes over visiting clinics.
   
• Moreover, many online pharmacies offer competitive pricing, discounts, and bundled deals on STD self-testing kits, making them an affordable option for consumers. Additionally, these platforms often provide resources such as informational guides and FAQs to assist users in effectively utilizing the products, driving the revenue growth in the segment.

North America: The U.S. STD self-testing market is forecasted to reach USD 359.3 million by 2034.
 

• In the U.S., there is an increase in cases of syphilis by approximately 80% from 2018 to 2022. According to CDC, the cases of syphilis rose from 115,000 in 2018 to 207,000 in 2022. As more people recognize the need for regular testing and early detection of STDs, the demand for self-testing kits is expected to increase in the country.
   
• Additionally, growing awareness among people towards timely diagnosis and treatment of STD’s is driving a shift in the market towards more convenient and private healthcare solutions such as self-test kits. This trend is expected to continue contributing to the growth of market in the U.S.
   
• Furthermore, services offered by vendors such as Everlywell, LetsGetChecked, and Nurx integrate self-testing with virtual consultations and treatment. This helps to enhance patient convenience. Availability of well-established telehealth infrastructure in the U.S. eases the accessibility of patients towards teleconsultation, further driving the demand for STD self-testing kits.
   

Europe: STD self-testing market in the UK is projected to grow significantly from 2025 to 2034.
 

• Uk’s well established healthcare system and the rising demand for advanced diagnostic tools are the key factors propelling the growth of the market. Government of UK consistently focus on checking the prevalence of sexually transmitted infections. For instance, total 672,576 chlamydia tests were carried out in 2023 in the UK. In order to curb the burden of STIs across diagnostic laboratories, the demand for self-test is expected to increase in the UK during the forecast period.
   
• Furthermore, growing adoption of telehealth technologies is also driving the use of self-test kits for diagnosing STI’s. According to the Government of UK, out of total 672,576 chlamydia tests conducted in 2023, about 42.7% were internet-based consultation, which increased by 0.8% in comparison to 2022.
   
• Moreover, implementation of national STD awareness programs such as “It Starts With Me" campaign and “National Chlamydia Screening Programme” is also expected to bolster the revenue growth in market.
   

Asia Pacific: STD self-testing market in the Japan is expected to show lucrative growth opportunities during the forecast period.
 

• Japan is experiencing a significant rise in syphilis cases in recent years, indicating the need for convenient testing options. For instance, according to the March 2024 study published by National Center for Biotechnology Information, the number of syphilis cases increased from 7,007 in 2018 to 13,258 in 2022. This sudden rise is making people opt for reliable testing options such as self-test kits.
   
• Moreover, Japan boasts a strong IVD and medical devices market, permitting the innovation and local production of STD test kits. For instance, according to the Japan Association of Clinical Reagents Industries, the reagent sales for the infectious disease diagnosis increased in Japan by 44.9% during 2020-2022.
   
• Furthermore, in Japan, people have access to universal health insurance which includes coverage for STD testing when symptoms are present. This, in addition to the increasing need for privacy, has led to self-test kits being more readily accepted. These factors are playing a crucial role in increasing the revenue of the market within the country.
   

Middle East and Africa: STD self-testing market in the Saudi Arabia is projected to grow significantly through 2034.
 

• The growth of the market is highly influenced by the increasing investment in healthcare infrastructure, including advanced medical devices, diagnostic tools such as STD self-testing kit in the country.
   
• Under Saudi Arabia’s Vision 2030, the government plans to invest over USD 65 billion to enhance healthcare infrastructure, which includes the development of health clusters and the expansion of health services.
   
• These efforts are expected to transform the healthcare landscape in Saudi Arabia, making self-testing options more accessible and widely adopted by consumers for managing their health.
   

STD Self-testing Market Share

The market is highly competitive, with both established players and new entrants consistently innovating and developing advanced products. In terms of revenue, the market is primarily dominated by leading firms such as OraSure Technologies, bioLytical Laboratories, LetsGetChecked, Biosure, Everlywell, and Wondfo which together account for approximately 35% of the total market share.
 

These established companies are focusing on the development of convenient technologies, to enhance precision and accuracy, enabling market players to strengthen their position in this growing sector. In order to maintain a competitive edge, these players are also increasing spending on R&D with the goals of enhancing accuracy, shortening turnaround times, and simplifying the workflow of the systems. Smaller players are focusing on low pricing strategies to sustain in the market.
 

STD Self-testing Market Companies

Some of the eminent market participants operating in the STD self-testing industry include:

• Atomo diagnostics
• autotest VIH
• bioLytical Laboratories
• BioSure
• Everlywell
• JAL Medical
• LetsGetChecked
• MedMira
• Meril Life Sciences
• My Lab Box
• NOWDiagnostics
• OraSure Technologies
• Selfdiagnostics
• Viatris
• Wondfo
   
• OraSure Technologies provides accessible and effective solutions for infectious disease detection. The company’s products are available in over 70 countries, expanding the reach of affordable healthcare solutions worldwide.
   
• bioLytical Laboratories has strong presence in Canada and European countries. The company offers rapid self-test that has the capability to deliver results in 1 minute.
   
• Wondfo is a manufacturer of diagnostic testing products, particularly known for its rapid diagnostic test kits. The company has established a global presence and is widely recognized for producing high-quality testing solutions in healthcare sector.
   

STD Self-testing Industry News:

• In March 2025, bioLytical Laboratories announced the launch of its INSTI Multiplex HIV-1/2 Syphilis Antibody Test in Australia. This dual HIV-syphilis test provides results in just 60 seconds and helps patients to opt for optimum care faster.
   
• In December of 2024, OraSure Technologies announced the acquisition of Sherlock Biosciences, Inc. This acquisition increases OraSure’s innovation pipeline expanding with the addition of Sherlock’s molecular diagnostics platform which is capable of delivering results with high sensitivity and specificity in a disposable format suitable for over the counter use. The first molecular self-test Sherlock’s is launching is for Chlamydia Trachomatis (CT) and Neisseria Gonorrhoeae (NG), which is expected to augment OraSure’s portfolio of rapid STI diagnostic tests, pending regulatory approvals.
   
• In January 2024, OraSure Technologies announced to enter into an extensive strategic distribution agreement with Sapphiros. From this cooperation, OraSure expects to provide an extensive range of low-cost diagnostic tests and sample management solutions to its customers worldwide.
   

The STD self-testing market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million from 2021 – 2034 for the following segments:

Click here to Buy Section of this Report

Market, By Application

• Chlamydia/Gonorrhea (CT/NG) testing
• Syphilis testing
• HIV testing
• Other applications

Market, By Sample Type

• Blood based test
• Urine based test
• Oral based test

Market, By Distribution Channel

• Hospital pharmacies
• Online pharmacies
• Retail pharmacies

The above information is provided for the following regions and countries:

• North America 
  • U.S.
  • Canada
• Europe 
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
• Asia Pacific 
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America 
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa 
  • South Africa
  • Saudi Arabia
  • UAE